ClinicalTrials.Veeva

Menu

Well Being And Resilience: Mechanisms of Transmission of Health and Risk (WARM)

S

Susanne Harder

Status

Completed

Conditions

Bipolar Disorder
Psychotic Disorder
Depressive Disorder

Treatments

Other: Biological and psycho-social risk and resilience factors

Study type

Observational

Funder types

Other

Identifiers

NCT02306551
DFF-1319-00103

Details and patient eligibility

About

The purpose of this study is to establish a cohort of pregnant women with severe mental disorder and to identify biological and psycho-social transmission mechanisms involved in the development of 'risk' and 'resilience' in the offspring. It is assumed that both 'resilient' and 'risk' development in offspring are caused by a complex interaction between multiple biological, psychological and social factors. The project focuses specifically on exploring the impact of physiological stress-sensitivity, attachment, care-giving and the familial and social context for care-giving. Previous studies support these factors as important for the development of these infants, but systematic research using a prospective design is needed to strengthen evidence and elucidate the importance of these factors in more detail. The interaction over time of physiological stress-sensitivity, attachment, care-giving and the familial and social context for care-giving are evaluated in terms of the evolution of very early indicators of developmental risk and resilience in infants with a known highly increased risk for developing a mental disorder.The findings of the study may potentially lead to more specific targets for preventive interventions, which can improve developmental outcome for these infants.

Enrollment

93 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women with Psychotic Disorder (DSM-5: Delusional Disorder (297.1)
  • Schizophreniform Disorder (295.4), Schizophrenia (295.90), Schizoaffective Disorder (295.70)
  • Brief Psychotic Disorder (298.8) Other specified schizophrenia spectrum and other psychotic disorder (298.8), Unspecified schizophrenia spectrum and other psychotic disorder (298.9) )
  • Lifetime diagnosis of DSM-5 Bipolar I and II Disorder (296.89)
  • Diagnosis of DSM-5 Major Depressive Disorder current single episode (current 296.22 - 296.25) or recurrent episode (296.32 - 296.35)
  • Non-psychiatric control group defined as mothers without any history of treatment or admission for a psychiatric disorder or drug or alcohol addiction.
  • Partners of participating women with an expected care-giving role in relation to the infant will also be eligible for participation in the study.
  • Infants of participating pregnant women will be included from birth.

Exclusion criteria

  • Unable to provide informed consent to participate
  • Unable to speak English or Danish because of the requirement to complete assessments,
  • Miscarriage.

Trial design

93 participants in 4 patient groups

Psychotic Disorder
Description:
Biological and psycho-social risk and resilience factors
Treatment:
Other: Biological and psycho-social risk and resilience factors
Bipolar Disorder
Description:
Biological and psycho-social risk and resilience factors
Treatment:
Other: Biological and psycho-social risk and resilience factors
Depressive Disorder
Description:
Biological and psycho-social risk and resilience factors
Treatment:
Other: Biological and psycho-social risk and resilience factors
Non-psychiatric Control
Description:
Biological and psycho-social risk and resilience factors
Treatment:
Other: Biological and psycho-social risk and resilience factors

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems